India.FinancialNirvana.com » Dr. Reddy’s

Dr. Reddy’s launches generic Proscar and Zocor in US

Rahul Rathi — Mon, 26 Jun 2006 02:02:20 +0000

Andhracafe: One of India’s largest pharmaceutical companies, Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) recently launched the generic versions of Merck & Co’s prostate cancer drug Proscar and Zocor in the US market after the expiry of Merck’s patents. Zocor is used to reduce cholesterol while Proscar is used to treat benign prostatic hyperplasia. Dr Reddy’s lab will be allowed to sell the generic version of drug’s Zocor and Proscar

This is certainly positive for the Dr. Reddy’s Lab , recent regulatory and much awaited patent law changes have lead the Indian Pharmaceutical Industry towards exploring newer avenues of drug development, thus, promising higher capital investment in the pharmaceutical industry in the near future. Companies like Dr Reddy and Ranbaxy are constantly moving further in revenue chain by improving their R&D and cutting cost. Strong government support and availability of surplus skilled technical workers at lower costs has helped them a lot.

6 Indian stocks on sale right now

Himanshu Pandya — Tue, 23 May 2006 22:18:01 +0000

With the recent slide in the BSE SENSEX you might want to look at the following stocks that seem to be on sale. The slide was bound to happen after a major uptrend that pushed the SENSEX to its highest point ever. There are no concerns of Indian economy softening anytime soon and therefore I am confident in picking up some of these stocks. The recent slide could be attributed to profit taking and global concerns including the US markets. You would want to build your positions slowly by buying small chunks.

Also remember that Indian stocks are a long term play.

1. SIFY (NASDAQ: SIFY) – Diversified internet company involved with anything to do with Internet in India. Infrastructure outsourcing will benefit Sify the most.
2. Tata Motors Inc. (NYSE: TTM) – Auto pick in the booming Indian auto sector. (The lackluster earnings also caused the decline in the case of Tata Motors)
3. HDFC Bank (NYSE: HDB) – Look at my article about Citigroup possibly buying out the bank after the liberalization in 2009.
4. ICICI Bank (NYSE: IBN) – Another pick in the red-hot Indian Banking sector.
5. DR. REDDYï¿½S LAB LTD (NYSE:RDY) – Pharmaceutical pick.
6. Wipro (NYSE: WIT) – Might reach single digit and would be worth picking up for a trade.

Full Disclosure: I own shares of SIFY

Dr. Reddy’s Laboratories Ltd. gets FDA approval for generic Allegra

Himanshu Pandya — Thu, 13 Apr 2006 16:32:00 +0000

Yahoo - Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) said on Thursday that it has received final approval from the Food and Drug Administration (FDA) for its generic version of allergy medication Allegra, and will begin commercial marketing immediately.

The stock is near its 52 week high but the downturn in the Indian market the last couple of days is clearly affecting the stock.